Lockdown Impact on Spontaneous Premature Birth in a Level III NICU
NCT ID: NCT04605172
Last Updated: 2022-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
812 participants
OBSERVATIONAL
2020-11-02
2021-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It has been shown that the risk of spontaneous prematurity increases particularly in case of working over 40 hours per week, hard physically conditions, or prolonged daily transport time. Rest is one of the most efficient measure to prevent PL and should be proposed to all pregnant women, and combined with other therapies such as tocolysis or cerclage when needed.
The very particular period of lockdown during the COVID-19 pandemic had pregnant women to drastically reduce their activity. They suspended their work and stayed home for various reasons such as pregnancy in progress, children at home, and also collective reasons such as teleworking or workplace closure.
During the lockdown period from March 17th to May 11th 2020, fewer preterm labor and less spontaneous prematurity have been suspected by the neonatology and obstetrics teams throughout the Lorraine region.
Our study aims to objectively confirm this observation. In this investigation we aim to find a relationship between lockdown, PL and spontaneous prematurity which would need to re-evaluate public health recommendations for pregnant women outside the lockdown.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of Virtual Reality for the Management of Hospitalized Pregnant Patients at Risk of Preterm Delivery
NCT05547724
Hospitalizations in Neonatal Period and Early Discharge of Maternity
NCT05550272
Impact of Suspected Preterm Labour on Cardiometabolic Profile and Neurodevelopment
NCT05211297
Discourse on the Mother's Decision Regarding the Mode of Delivery in Cases of Breech Presentation
NCT07314970
6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks
NCT07146451
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lockdown Group
newborn born prematurely during confinement (1st March - 1st June 2020)
hospitalization for premature birth
Number of inborn and outborn infants prematurely born during a specific period of time
Control group
newborn born prematurely in comparative years over the same period (1st March - 1st June from 2015 to 2019)
hospitalization for premature birth
Number of inborn and outborn infants prematurely born during a specific period of time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hospitalization for premature birth
Number of inborn and outborn infants prematurely born during a specific period of time
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
0 Days
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean-Michel HASCOET
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maternite Regionale Universitaire CHRU NANCY
Nancy, Lorraine, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020PI168
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.